|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication November 23, 2005.
Revised March 1, 2006.
Accepted for publication March 1, 2006.
B activation in macrophages
In the course of screening inhibitors of MMP-9 induction
in macrophages, we isolated decursin, a coumarin
compound, from the roots of Angelicae gigas. As a marker
for the screening and isolation, we tested expression of
MMP-9 in RAW264.7 cells and THP-1 cells after treatment
with bacterial lipopolysaccharide (LPS), the TLR-4
ligand. Decursin suppressed MMP-9 expression in cells
stimulated LPS in a dose dependent manner at
concentrations below 60 µM without any sign of
cytotoxicity. The suppressive effect of decursin was
also observed not only in cells stimulated with ligands
for TLR4, TLR2, TLR3, and TLR9 but also in cells
stimulated with interleukin (IL)-1
and tumor
necrosis factor (TNF)-
indicating that the
molecular target of decursin is common signaling
molecules induced by these stimulants. In addition to
the suppression of MMP-9 expression, decursin blocked
nitric oxide production and cytokine (IL-8, MCP-1, IL-1&
[beta] and TNF-
) secretion induced by LPS. In
order to find out the molecular mechanism responsible
for the suppressive effect of decursin, we analyzed
signaling molecules involved in the TLR-mediated
activation of MMP-9 and cytokines. Decursin blocked
phosphorylation of I
B and nuclear translocation
of NF-
B in THP-1 cells activated with LPS.
Furthermore, expression of a luciferase reporter gene
under the promoter containing NF-
B binding sites
was blocked by decursin. These data indicate that
decursin is a novel inhibitor of NF-
B activation
in signaling induced by TLR ligands and cytokines.
Key words:
Tumor necrosis factor, NFkappaB, Leukocytes/Mast cells